New insights: Elevated follicle-stimulating hormone and bone loss during the menopausal transition

Current Rheumatology Reports

Volumn 11, Issue 3, 2009, Pages 191-195

  Zaidi, Mone ^a   Blair, Harry C ^b   Iqbal, Jameel ^b   Davies, Terry F ^b   Zhu, Ling Ling ^b   Zallone, Alberta ^b   Sun, Li ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FOLLITROPIN; FOLLITROPIN RECEPTOR; I KAPPA B ALPHA; INHIBIN; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

BONE MASS; BONE STRENGTH; CLIMACTERIUM; CYTOKINE PRODUCTION; FOLLITROPIN BLOOD LEVEL; HORMONE ACTION; HUMAN; HYPOGONADISM; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TRABECULAR BONE; ANIMAL; ARTICLE; BLOOD; DISEASE MODEL; DRUG ANTAGONISM; FEMALE; METABOLISM; MOUSE; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS;

ANIMALS; BONE RESORPTION; DISEASE MODELS, ANIMAL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MICE; OSTEOCLASTS; OSTEOPOROSIS, POSTMENOPAUSAL; PERIMENOPAUSE; RECEPTORS, FSH;

EID: 70349580382     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-009-0026-0     Document Type: Review

References (33)

1. F. Albright P.H. Smith A.M. Richardson 1941 Post menopausal osteoporosis JAMA 1167 2465 2474
2. B.L. Riggs S. Khosla L.J. Melton 3rd 2002 Sex steroids and the construction and conservation of the adult skeleton Endoc Rev 23 279 302 10.1210/er.23.3.279 1:CAS:528:DC%2BD38XltlWjtrs%3D (Pubitemid 34651948)
3. N.K. Shevde A.C. Bendixen K.M. Dienger J.W. Pike 2000 Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-jun repression Proc Natl Acad Sci 97 7829 7834 10869427 10.1073/pnas.130200197 1:CAS:528:DC%2BD3cXkvFCntb8%3D (Pubitemid 30460733)
4. S. Srivastava G. Toraldo M.N. Weitzmann, et al. 2002 Estrogen decreases osteoclast formation by downregulating receptor activator for NF-kappa B ligand induced JNK activation J Biol Chem 276 8836 8840 10.1074/jbc.M010764200
5. S. Srivastava M.N. Weitzmann R.B. Kimble, et al. 1998 Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1 J Clin Invest 102 1850 1859 9819371 10.1172/JCI4561 1:CAS:528:DyaK1cXns1Omsrw%3D
6. C. Roggia Y. Gao S. Cenci, et al. 2001 Up-regulation of TNF producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo Proc Natl Acad Sci 98 13960 13965 11717453 10.1073/pnas.251534698 1:CAS:528:DC%2BD3MXovVynuro%3D (Pubitemid 33116006)
7. V. García Palacios L.J. Robinson C.W. Borysenko, et al. 2005 Negative regulation of RANKL induced osteoclastic differentiation in RAW264.7 cells by estrogen and phytoestrogens J Biol Chem 280 13720 13727 15644335 10.1074/jbc.M410995200 (Pubitemid 40517267)
8. K.E. Armour K.J. Armour M.E. Gallagher, et al. 2001 Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase Endocrinology 142 760 766 11159848 10.1210/en.142.2.760 1:CAS:528:DC%2BD3MXhtFSrt74%3D (Pubitemid 32222425)
9. C.J. Jagger J.W. Chow T.J. Chambers 1996 Estrogen suppresses activation but enhances formation phase of osteogenic response to mechanical stimulation in rat bone J Clin Invest 98 2351 2357 8941653 10.1172/JCI119047 1:CAS:528:DyaK28XntVOhsbg%3D
10. J.F. Randolph M. Sowers I.V. Bondarenko, et al. 2004 Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age J Clin Endocrinol Metabol 89 1555 1561 10.1210/jc.2003-031183 1:CAS:528:DC%2BD2cXjt1els7g%3D (Pubitemid 38507902)
11. M.R. Sowers M. Jannausch D. McConnell, et al. 2006 Hormone predictors of bone mineral density changes during the menopausal transition J Clin Endocrinol Metabol 91 1261 1267 10.1210/jc.2005-1836 1:CAS:528:DC%2BD28XjvFOks7k%3D
12. R. Recker J. Lappe K.M. Davies R. Heaney 2004 Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients J Bone Miner Res 19 1628 1633 15355557 10.1359/JBMR.040710 (Pubitemid 41094325)
13. M.P. Akhter J.M. Lappe K.M. Davies R.R. Recker 2007 Transmenopausal changes in the trabecular bone structure Bone 41 111 116 17499038 10.1016/j.bone.2007.03.019 1:STN:280:DC%2BD2szls1ensQ%3D%3D (Pubitemid 46891901)
14. L. Sun Y. Peng A.C. Sharrow, et al. 2006 FSH directly regulates bone mass Cell 125 247 260 16630814 10.1016/j.cell.2006.01.051 1:CAS:528: DC%2BD28Xkt1Oqtbs%3D
15. Y. Wu J. Torchia W. Yao, et al. 2007 Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen deficiency PLoS ONE 2 e586 17611621 10.1371/journal.pone.0000586
16. J. Iqbal L. Sun T.R. Kumar, et al. 2006 Follicle stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation Proc Natl Acad Sci 103 14925 14930 17003115 10.1073/pnas.0606805103 1:CAS:528:DC%2BD28XhtVygsrjJ (Pubitemid 44527830)
17. J. Gao R. Tiwari-Pandey R. Samadfam, et al. 2007 Altered ovarian function affects skeletal homeostasis independent of the action of follicle stimulating hormone Endocrinology 148 2613 2621 17332067 10.1210/en.2006-1404 1:CAS:528:DC%2BD2sXmt1ajtrs%3D (Pubitemid 46984812)
18. C. Miyaura K. Toda M. Inada, et al. 2001 Sex- and age-related response to aromatase deficiency in bone Biochem Biophys Res Commun 280 1062 1068 11162635 10.1006/bbrc.2001.4246 1:CAS:528:DC%2BD3MXnvFOjsQ%3D%3D (Pubitemid 32924448)
19. N.A. Sims S. Dupont A. Krust, et al. 2002 Deletion of estrogen receptors reveals a regulatory role for estrogen receptorbeta in bone remodeling in females but not in males Bone 30 18 25 11792560 10.1016/S8756-3282(01)00643-3 1:CAS:528:DC%2BD38XktFeruw%3D%3D (Pubitemid 34044296)
20. T. Nakamura Y. Imai T. Matsumoto, et al. 2007 Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts Cell 130 811 823 17803905 10.1016/j.cell.2007.07.025 1:CAS:528:DC%2BD2sXhtV2ntL%2FI (Pubitemid 47332572)
21. B. Dawson-Hughes 2001 Bone loss accompanying medical therapies N Engl J Med 345 989 992 11575293 10.1056/NEJM200109273451310 1:STN:280: DC%2BD3MrivVyksA%3D%3D (Pubitemid 34940817)
22. M.R. Sowers G.A. Greendale J. Bondarenko, et al. 2003 Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN Ost Internat 14 191 197 1:CAS:528:DC%2BD3sXlslOls7k%3D
23. Z.R. Xu A.H. Wang X.P. Wu, et al. 2009 Relationship of agerelated concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women Clin Chim Acta 400 8 13 18930719 10.1016/j.cca.2008.09.027 1:CAS:528:DC%2BD1MXht1GlsA%3D%3D
24. B. Devleta B. Adem S. Seneda 2004 Hypergonadotropic amenorrhea and bone density: new approach to an old problem J Bone Min Res 22 360 364
25. D. Gaddy-Kurten J.K. Coker E. Abe, et al. 2002 Inhibin suppresses and activin stimulates osteoclastogenesis and osteoclastogenesis in murine bone marrow cultures Endocrinology 143 74 83 11751595 10.1210/en.143.1.74 1:CAS:528:DC%2BD38XjtVOrsw%3D%3D (Pubitemid 34056405)
26. M. Eijken S. Swagemakers M. Koedam, et al. 2007 The activin Afollistatin system: potent regulator of human extracellular matrix mineralization FASEB J 21 2949 2960 17449718 10.1096/fj.07-8080com (Pubitemid 47372761)
27. K.M. Nicks N.S. Akel L. Liu, et al. 2008 Physiological concentrations of inhibin A are anabolic, affecting both trabecular and cortical bone in normal intact mice J Bone Min Res 23 S417 10.1359/jbmr.071032 (Pubitemid 351304672)
28. R. Kalak C.M. Allan K.J. McTavish, et al. 2008 Transgenic expression of human FSH in female mice has an anabolic effect on bone J Bone Min Res 23 S63
29. E. Abe R.C. Marians W. Yu, et al. 2003 TSH is a negative regulator of skeletal remodeling Cell 115 151 162 14567913 10.1016/S0092-8674(03)00771-2 1:CAS:528:DC%2BD3sXosFCqsL4%3D (Pubitemid 37329579)
30. H. Hase T. Ando L. Eldeiry, et al. 2006 TNFalpha mediates the skeletal effects of thyroid-stimulating hormone Proc Natl Acad Sci U S A 103 12849 12854 16908863 10.1073/pnas.0600427103 1:CAS:528:DC%2BD28XptVymtrk%3D (Pubitemid 44298650)
31. L. Sun S. Vukicevic R. Baliram, et al. 2008 Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss Proc Natl Acad Sci U S A 105 4289 4294 18332426 10.1073/pnas.0712395105 1:CAS:528:DC%2BD1cXktF2gsrY%3D (Pubitemid 351754373)
32. K.L. Britt A.E. Drummond M. Dyson, et al. 2001 The ovarian phenotype of the aromatase knockout (ArKO) mouse J Steroid Biochem Mol Biol 79 181 185 11850223 10.1016/S0960-0760(01)00158-3 1:CAS:528:DC%2BD38XhtFyltbs%3D (Pubitemid 34158793)
33. J.F. Couse M.M. Yates V.R. Walker, et al. 2003 Characterization of the hypothalamic-pituitary-gonadal axis in estrogen receptor (ER) null mice reveals hypergonadism and endocrine sex reversal in females lacking ERalpha but not ERbeta Mol Endocrinol 17 1039 1053 12624116 10.1210/me.2002-0398 1:CAS:528:DC%2BD3sXktlymsbY%3D (Pubitemid 36683712)